Consolidated Statements of Stockholders' Equity - USD ($)	Total	Preferred Stock	Common Stock	Capital in Excess of Par	Accumulated Other Comprehensive Loss	Accumulated Deficit	Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock, Ending balance		$ 0
Common stock, Ending balance			$ 121,715
Preferred stock, Beginning balance (in shares) at Dec. 31, 2022		0
Preferred stock, Beginning balance at Dec. 31, 2022		$ 0
Common stock, Beginning balance (in shares) at Dec. 31, 2022			12,171,512
Common stock, Beginning balance at Dec. 31, 2022			$ 121,715
Stockholders' equity beginning of period at Dec. 31, 2022	$ 36,169,432			$ 74,519,590	$ (15,958,428)	$ (16,945,964)	$ (5,567,481)
Treasury stock, Beginning balance (in shares) at Dec. 31, 2022							1,471,406
Stockholders' equity end of period at Dec. 31, 2023	34,504,139			75,338,010	(12,274,563)	(23,114,310)	$ (5,567,481)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	832,597			832,597
Vesting of restricted stock awards (in shares)			82,865
Vesting of restricted stock awards	$ 0		$ 828	(828)
Exercise of stock options (in shares)	0
Shares deducted from restricted stock awards for payment of withholding taxes (in shares)			(6,064)
Shares deducted from restricted stock awards for payment of withholding taxes	$ (13,409)		$ (60)	(13,349)
Net (loss) income	(6,168,346)					(6,168,346)
Decrease in unrealized losses on available- for-sale securities, net of tax	$ 3,683,865				3,683,865
Preferred stock, Ending balance (in shares) at Dec. 31, 2023		0
Common stock, Ending balance (in shares) at Dec. 31, 2023	10,776,907		12,248,313
Treasury stock, Ending balance (in shares) at Dec. 31, 2023	1,471,406						1,471,406
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock, Ending balance		$ 0
Common stock, Ending balance			$ 122,483
Preferred stock, Beginning balance at Dec. 31, 2023		0
Common stock, Beginning balance at Dec. 31, 2023			$ 122,483
Stockholders' equity end of period at Dec. 31, 2024	$ 66,708,451			89,063,326	(12,175,476)	(4,755,874)	$ (5,568,007)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,382,912			1,382,912
Vesting of restricted stock awards (in shares)			518,405
Vesting of restricted stock awards		$ 0	$ 5,184	(5,184)
Exercise of stock options (in shares)			71,997				52,719
Exercise of stock options	63,711		$ 721	63,516			$ (526)
Issuance of common stock, net of offering costs of $427,779 (in shares)			1,437,287
Issuance of common stock, net of offering costs of $427,179	13,610,807		$ 14,370	13,596,437
Exercise of warrants (in shares)			304,413
Exercise of warrants			$ 3,045	(3,045)
Shares deducted from restricted stock awards for payment of withholding taxes (in shares)			(132,210)
Shares deducted from restricted stock awards for payment of withholding taxes	(1,310,641)		$ (1,321)	$ (1,309,320)
Net (loss) income	18,358,436					$ 18,358,436
Decrease in unrealized losses on available- for-sale securities, net of tax	$ 99,087				$ 99,087
Preferred stock, Ending balance (in shares) at Dec. 31, 2024		0
Common stock, Ending balance (in shares) at Dec. 31, 2024	12,924,080		14,448,205
Treasury stock, Ending balance (in shares) at Dec. 31, 2024	1,524,125						1,524,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock, Ending balance		$ 0
Common stock, Ending balance			$ 144,482